Get the Stockscreener App
1.59
0.00%
0.00
After Hours:
1.59
Genenta Science Spa Adr stock is traded at $1.59, with a volume of 37,282.
It is up +0.00% in the last 24 hours and down -12.15% over the past month.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
See More
Previous Close:
$1.59
Open:
$1.6364
24h Volume:
37,282
Relative Volume:
0.03
Market Cap:
$76.66M
Revenue:
-
Net Income/Loss:
$-7.33M
P/E Ratio:
-4.2823
EPS:
-0.3713
Net Cash Flow:
$-8.02M
1W Performance:
+0.63%
1M Performance:
-12.15%
6M Performance:
+3.25%
1Y Performance:
-57.94%
1-Day Range:
$1.59
$1.69
1-Week Range:
$1.52
$1.70
52-Week Range:
$0.55
$10.00
Genenta Science Spa Adr Stock (GNTA) Company Profile
Name
Genenta Science Spa Adr
Sector
Industry
Phone
-
Address
-
Compare GNTA vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GNTA
Genenta Science Spa Adr
|
1.59 | 76.66M | 0 | -7.33M | -8.02M | -0.3713 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-29-23 | Resumed | ROTH MKM | Buy |
| Jul-25-22 | Initiated | H.C. Wainwright | Buy |
| Jan-13-22 | Initiated | Maxim Group | Buy |
Genenta Science Spa Adr Stock (GNTA) Latest News
Genenta Science SpA Sponsored ADR Revenue Breakdown – MUN:K5F - TradingView
Genenta-backed Sòphia High Tech Brings Aerospace Precision Inside a Nuclear Fusion Reactor with ROMAN, a Robotic Arm - GlobeNewswire Inc.
Genenta-backed Sòphia sales rise 29.3% to €7.17 million - grafa.com
The market is filled with gapping stocks in Wednesday's session. - ChartMill
Genenta Science Regains Full Effectiveness of Corporate Purpose Amendment After Milan Court Ruling - TipRanks
Genenta Science Confirms New Board, Share Buyback and Closes Sòphia High Tech Deal - TipRanks
GENENTA SCIENCE SPAADR (GNTA) Stock Chart - ChartMill
Enterprise value to EBITDA forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Enterprise value to EBIT forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Enterprise value to revenue forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Price to earnings forward of Genenta Science SpA Sponsored ADR – FWB:K5F - TradingView
Genenta Science Faces Court-Ordered Suspension of Corporate Purpose Amendment While Voting Rights Reform Stands - The Globe and Mail
Genenta Science SpA Sponsored ADR Actuals & Estimates (NASDAQ:GNTA) - TradingView
Genenta Science Sets CEO Severance Terms and Narrows Non-Compete in June 2026 - The Globe and Mail
Genenta Calls June 29 Shareholder Vote on Name Change, Capital Moves and Reverse Split - The Globe and Mail
Genenta Science regains compliance with Nasdaq minimum bid price rule By Investing.com - Investing.com Australia
Genenta Science regains compliance with Nasdaq minimum bid price rule - Investing.com
Genenta Science Regains Compliance with Nasdaq Minimum Bid Price Rule - TipRanks
Genenta sale al 100% della brianzola Atc (fucili per le forze speciali) e nomina il generale Luca Goretti nel cda - Milano Finanza
Unusual volume stocks in Tuesday's session - ChartMill
Which stocks have an unusual volume on Monday? - ChartMill
Which stocks are moving on Monday? - ChartMill
Monday's session: gap up and gap down stocks - ChartMill
Wondering what's happening in today's pre-market session? - ChartMill
Genenta Science Closes All-Share Acquisition of Remaining Stake in A.T.C. - The Globe and Mail
GNTAGenenta Science SpA ADR Options - Finviz
On Friday, there are stocks with unusual volume. Let's take a look. - ChartMill
Wondering what's happening in today's after-hours session? - ChartMill
GNTA Stock Price, Quote & Chart | GENENTA SCIENCE SPAADR (NASDAQ:GNTA) - ChartMill
Genenta Science Ends Ospedale San Raffaele License to Refocus Strategy - TipRanks
Genenta Science to Close U.S. Subsidiary and Shift CFO to Consulting Role - The Globe and Mail
Genenta Science to close US subsidiary and transition CFO to consulting role - Investing.com Canada
Genenta Science to close US subsidiary and transition CFO to consulting role By Investing.com - Investing.com South Africa
Unusual VolumeStock ScreenerNews - Finviz
Genenta Science Moves Into Aerospace With Majority Investment Deal for Sòphia High Tech - The Globe and Mail
Genenta Science Warned by Nasdaq Over Minimum Bid Price Compliance - The Globe and Mail
Genenta Science receives Nasdaq notice on minimum bid price compliance By Investing.com - Investing.com India
Genenta Science receives Nasdaq notice on minimum bid price compliance - Investing.com
What's going on in today's pre-market session - chartmill.com
Genenta Moves to Acquire Control of Italian Space-Defense Supplier Sòphia High Tech - TipRanks
Genenta Science Cancels Late-March Vote on Rebrand to Saentra Forge - The Globe and Mail
Genenta Science Spa Adr Stock (GNTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):